CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion Roya DadmarzMagdalene K. SgagiasDouglas J. Schwartzentruber Original Article Pages: 1 - 9
Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice Takeshi JimboToshihiko AkimotoAkiko Tohgo Original Article Pages: 10 - 16
Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene Yoshimi IwanumaKazunori KatoKo Okumura Original Articles Pages: 17 - 23
Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assays Marrije R. BuistPeter KenemansHidde J. Haisma Original Article Pages: 24 - 30
Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction José Alexandre M. BarbutoWilliam J. GrimesEvan M. Hersh Original Article Pages: 31 - 36
Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19 L. Tom VlasveldAnnemarie HekmanElaine M. Rankin Original Article Pages: 37 - 47
Induction of an autoimmune response against syngeneic lymphoma cells by immunogenic 64-kDa protein isolated from normal blast cells of BALB/c mice Roberto StockDavid Naor Original Article Pages: 48 - 56
Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated myramyl-tripeptide-phosphatidylethanolamine Diana RisinEugenie S. KleinermanNeal R. Pellis Original Article Pages: 57 - 64
Heterogeneity of murine adherent interleukin-2-activated killer cells differential effect of prostaglandin E2 and forskolin Dominique VaillierRichard DaculsiNorbert Gualde Original Article Pages: 65 - 71
